Analysts/Institutional Investor Meet/Con. Call Updates

August 23, 2026 SBIL/CS/NSE-BSE/2627/93 Vice President General Manager Listing Department, Listing Department, National Stock Exchange of India Limited, BSE Limited, Exchange Plaza, Phiroze Jeejeebhoy Towers, Plot No. C/1, G Block, BKC, Dalal Street, Bandra (East), Mumbai 400051 Mumbai 400001 NSE Symbol: SBILIFE BSE Scrip Code: 540719 Dear Sir / Madam, Subject: Disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 Pursuant to the Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find below the schedule of meeting with investor(s)/analyst(s) to be held where the senior management of the Company intends to interact with the investor(s)/analyst(s). Sr. No. Conference hosted by Location Date 1 Morgan Stanley - India Financials Mumbai August 27, 2026 Investor Group Trip The schedule of the aforesaid meeting is subject to change, if any due to exigencies on the part of Investor / Company. Please note that no unpublished price sensitive information shall be shared during the meeting(s). This is for your information and appropriate dissemination. Thanking You, Your faithfully, Girish Manik Company Secretary ACS No. 26391 Public SBI Life Insurance Company Ltd. Registered and Corporate Office: Natraj, M.V. Road and Western Express Highway Junction Andheri (East), Mumbai 400 069. Tel.: (022) 6191 0000/ 3968 0000 IRDAI Regn. No. 111. CIN: L99999MH2000PLC129113 www.sbilife.co.in